“Because we run high-fidelity patient-specific models, the computational demands are substantial, and the use of TACC allows us to explore various modeling approaches in a much more efficient manner,” Sacks said. “We can now explore in-silico in days what used to take weeks or even months to simulate.”

Sacks has been an active user of advanced computing resources from the Texas Advanced Computing Center (TACC) at UT Austin since 2011. For this research, Sacks and his research team used TACC’s Lonestar5 and Stampede2 supercomputers.

“Our models combined the complete 3D geometry of the mitral valve in the open and closed states, making possible an unparalleled level of predictive accuracy,” Sacks said. “To model the MV leaflets, we then integrated into the MV models the structure and mechanical properties of the internal constituents, such as the collagen fibers which make up most of the valve, to develop attribute-rich complete MV models.”

Several studies have shown significant deficiencies in the long-term success of current surgical approaches to treating common heart valve diseases. Up to 60 percent of patients who have undergone MV regurgitation surgery report recurrence just two years after the surgery.

“Cardiac surgeons must decide upon the best possible treatment for heart valve repair without knowing all the facts,” said Robert Gorman, professor of surgery in the Perelman School of Medicine at the University of Pennsylvania and a key collaborator on the study. “Most rely on their own experiences or how they were taught to perform valve repair surgery in medical school.”

With the researchers’ new computational predictive technique, surgeons won’t have to take the previous one-size-fits-all approach to MV leaflet repair.

Sacks said, “The current computational model is a step forward because it utilizes and is derived from patient-specific imaging data. We can now accurately predict what the post-surgical state of the microvalve will be based on pre-surgical data.”

“The computational modeling tool we’ve developed will eliminate a lot of the uncertainty and allow for patient specificity,” Gorman said. “This will be transformative for those working in the field.”

The next steps for Sacks and his research team is to conduct multi-center trials as part of commercializing their technique.

“Once heart surgeons gain access to this tool in a clinical setting, we anticipate significant improvements in the long-term well-being of patients who’ve undergone mitral valve surgery,” he said.

The study was funded by the National Institutes of Health.


Source: Faith Singer-Villalobos, TACC